Bio Green Med Solution is trading at $0.93, up 5.19%, with broader market strength potentially contributing.

  • No September 30 company announcement appears in the company’s news-release listings; the latest listed release is dated August 12.
  • A merger-related shareholder investigation was reported September 28–29, but sources do not connect it to the move.
  • The S&P 500 was up 0.51% and Nasdaq was up 0.90%; no specific Bio Green Med Solution catalyst or trading-volume details were identified.